PDF is available of LRG Science here.
The LRG and NIH Collaborate on Virtual Tumor Boards to Review Challenging Cases
In this issue of LRG Science, we highlight the power of collaboration in medicine with a recap of the Virtual Tumor Boards co-hosted with the NIH.
Since there was no in-person Pediatric and Wildtype GIST Clinic at the NIH this year due to the pandemic, The Life Raft Group was asked to organize a Virtual Tumor Board to assure that challenging cases were presented in order to help the patients and their treating physicians develop an effective treatment plan.
The Life Raft Group and the NIH have a long history of collaborative efforts to support patients with the rare subsets of GIST that impact younger patients.
Also in this issue is thoughtful commentary by Dr. Abhenil Mittal and Dr. Sameer Rastogi of the Department of Medical Oncology at the All India Institute of Medical Sciences, New Delhi, in response to a previous study, titled, “Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine inhibitors: results from Life Raft Group Registry” published in LRG Science, April 2020.
LRG Science endeavors to be a respected source of timely, science-based information built on real world data designed for those whose focus is to increase patient survival from Gastrointestinal Stromal Tumor (GIST) and other cancers.
Commentary is welcome.
We welcome article submissions for 2020 & 2021. To inquire further or to submit commentary, please email Mary Garland: mgarland@liferaftgroup.org
